Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:07 PM
Ignite Modification Date: 2025-12-25 @ 12:21 PM
NCT ID: NCT00586261
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00586261
Study Brief: Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Pioglitazone Pioglitazone 30 mg daily for six months None None 1 17 1 17 View
Placebo Placebo 30 mg daily for six months None None 0 19 0 19 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
hypoglycemia SYSTEMATIC_ASSESSMENT Endocrine disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
edema SYSTEMATIC_ASSESSMENT Vascular disorders None View